Abiopharma

News list

Director Frias James D 🟢 acquired 32 shares (1 derivative) of CARLISLE COMPANIES INC (CSL) Transaction Date: Sep 01, 2026 | Filing ID: 000006

Full text

News bot Sept. 2, 2026, 10:01 p.m.
🔍 Frias James D (Director)

Company: CARLISLE COMPANIES INC (CSL)

Report Date: 2026-09-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 32
Detailed Transactions and Holdings:
- Acquired 32 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,704.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2
Footnotes:
- F1: Represents additional restricted stock units acquired as a result of the quarterly dividend declared and paid by the issuer. Each restricted stock unit represents a right to receive one share of the issuer's common stock.
- F2: The restricted stock units were fully vested on the date of grant and the vested shares will be delivered to the reporting person upon the reporting person's termination of service as a director of the issuer.